1. Copyright Notice
This presentation is copyrighted by the Psychopharmacology Institute.
Subscribers can download it and use it for professional use.
The contents of the presentation may be modified, but the Psychopharmacology Institute logo must remain visible in all slides.

2. Simon Kung, M.D. Associate Professor of Psychiatry Mayo Clinic
rTMS Summary
Simon Kung, M.D. Associate Professor of Psychiatry Mayo Clinic

3. rTMS is a noninvasive, brain-stimulation outpatient treatment for moderate-to-severe depression.
56%
The response rate is about 56% in open label trials.
The results are comparable to antidepressants.
There are very few side effects of TMS, mostly pain where the magnet is stimulating. Side effects are tolerable. 

4. More insurance companies in the United States are covering TMS. 
A lot of research regarding TMS is continuing.

5. Bermudes, RA. et al. (2018). Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice.  American Psychiatric Association Publishing.
General overview and reference about TMS
McClintock, S. M. et al. (2018). Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. The Journal of Clinical Psychiatry, 79(1).
Consensus recommendations for using TMS for depression
Literature review 
Expert opinion
Image of 2018 book:
Second image

6. Perera, T. et al. (2016). The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimulation, 9(3),
Consensus and treatment recommendations for major depression
Literature review
Member survey
Lefaucheur, J. P. et al. (2014). Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology, 125(11),
Evidence-based guidelines
Neurologic and psychiatric conditions